Sunshine Biopharma (SBFM) Interest Coverage Ratio: 2012-2024
Historic Interest Coverage Ratio for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to -238.92.
- Sunshine Biopharma's Interest Coverage Ratio fell 505.93% to -238.92 in Q4 2024 from the same period last year, while for Dec 2024 it was -65.44, marking a year-over-year decrease of 53.81%. This contributed to the annual value of -662.43 for FY2024, which is 1800.74% down from last year.
- According to the latest figures from Q4 2024, Sunshine Biopharma's Interest Coverage Ratio is -238.92, which was up 95.38% from -5,176.64 recorded in Q2 2024.
- In the past 5 years, Sunshine Biopharma's Interest Coverage Ratio registered a high of -1.99 during Q2 2021, and its lowest value of -858,990.00 during Q3 2022.
- Over the past 3 years, Sunshine Biopharma's median Interest Coverage Ratio value was -167.01 (recorded in 2024), while the average stood at -86,581.68.
- Per our database at Business Quant, Sunshine Biopharma's Interest Coverage Ratio plummeted by 8,109,137.82% in 2022 and then skyrocketed by 100.00% in 2023.
- Quarterly analysis of 5 years shows Sunshine Biopharma's Interest Coverage Ratio stood at -3.26 in 2020, then plummeted by 134.44% to -7.63 in 2021, then plummeted by 11,429.02% to -880.12 in 2022, then spiked by 95.52% to -39.43 in 2023, then slumped by 505.93% to -238.92 in 2024.
- Its Interest Coverage Ratio was -238.92 in Q4 2024, compared to -5,176.64 in Q2 2024 and -27.46 in Q1 2024.